NCT06439420

Brief Summary

This study seeks to investigate an evidence-based, manualized, behavioral health intervention, Cognitive Behavioral Therapy for Insomnia (CBT-I), in individuals with primary brain tumors (PBT) and insomnia. Our project will assess the feasibility and acceptability of recruitment, enrollment, data collection procedures, and retention of individuals with PBT and insomnia in the behavioral health intervention, CBT-I, and investigate the potential benefits of CBT-I within this at-risk and understudied population. In the long term, the goals are to expand treatment options for neuro-oncology patients and improve their mission readiness and overall wellbeing.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Jul 2024

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 28, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 3, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

July 8, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 25, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 25, 2025

Completed
Last Updated

October 1, 2025

Status Verified

September 1, 2025

Enrollment Period

1.2 years

First QC Date

May 28, 2024

Last Update Submit

September 30, 2025

Conditions

Keywords

Brain TumorInsomniaGliomaSleep

Outcome Measures

Primary Outcomes (9)

  • Rate of consent to screening procedures

    Number of participants that consent to screening procedures

    Baseline (Day 1)

  • Rate of those eligible enrolling

    Number of participants that are eligible to enroll to the protocol

    Baseline (Day 1)

  • Rate of baseline assessment completion

    Number of participants that complete the baseline assessment

    Week 1

  • Rate of post-intervention assessment completion

    The number of participants that complete the post-intervention assessment

    Week 6

  • Rate of follow-up assessment completion

    The number of participants that complete the follow-up assessment

    Week 18

  • Rate of intervention attrition

    The number of participants that do not complete the CBT-I intervention

    Week 6

  • Acceptability of quantity of assessments

    Satisfaction rating of quantity of assessments on a scale of 1-5 with 5 being the best

    Week 18

  • Acceptability of timing of assessments

    Satisfaction ratings of timing of assessments on a scale of 1-5 with 5 being the best

    Week 18

  • Acceptability of duration of assessments

    Satisfaction ratings of duration of assessments on a scale of 1-5 with 5 being the best

    Week 18

Study Arms (2)

Telehealth Cognitive Behavioral Therapy for Insomnia

EXPERIMENTAL
Behavioral: Cognitive Behavioral Therapy for Insomnia

Enhanced Treatment as Usual

NO INTERVENTION

Interventions

CBT-I is a non-pharmacological approach to treating sleep disturbance consisting of educational, behavioral, and cognitive intervention components with evidence-based strategies including sleep efficiency, stimulus control, and sleep hygiene modification. CBT-I includes at least 6 group sessions, each approximately 90 minutes in length, delivered over 6 weeks via telehealth.

Telehealth Cognitive Behavioral Therapy for Insomnia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Primary brain tumor diagnosis (grade I-IV)
  • \>/=2weeks post-cranial resection (if applicable)
  • \>/=1 month post-radiation therapy (if applicable)
  • Able to understand, speak, and read English
  • Absence of major cognitive concerns
  • Meet Diagnostic and statistical manual of mental disorders version 5 (DSM-V) diagnostic criteria for insomnia
  • Reliable internet connection

You may not qualify if:

  • Major communication difficulties that would prohibit effective intervention
  • Inability to attend weekly virtual group meetings
  • Inability to understand and provide informed consent
  • Currently a prisoner or residing in a correctional facility

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Virginia Commonwealth University

Richmond, Virginia, 23298, United States

Location

MeSH Terms

Conditions

Brain NeoplasmsGlioblastomaAstrocytomaOligodendrogliomaMeningiomaLymphomaSleep Initiation and Maintenance DisordersGlioma

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Central Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteNeoplasmsBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeoplasms, NeuroepithelialNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms by Histologic TypeNeoplasms, Glandular and EpithelialNeoplasms, Nerve TissueNeoplasms, Vascular TissueMeningeal NeoplasmsLymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesImmunoproliferative DisordersImmune System DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Ashlee Loughan, Ph.D

    Virginia Commonwealth University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2024

First Posted

June 3, 2024

Study Start

July 8, 2024

Primary Completion

September 25, 2025

Study Completion

September 25, 2025

Last Updated

October 1, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

There are no plans to share individual participant data.

Locations